BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"J.S. Elborn"”

28 results

Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort

Verified

Anthony De Soyza, T. F. Saunders, Georgina Wild, Phil Mawson et al.

Journal: ERJ Open ResearchYear: 2024Citations: 2

Background Bronchiectasis is associated with psychological comorbidity and poor quality of life (QoL), yet guidelines lack focus on psychological morbidity. Using data obtained from the BronchUK database (1341 patients), we examined the link between anxiety/depression and physical disease severity, ...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

Molecular conservation within LES9F and PS21 Liverpool epidemic strain (LES) markers in wild-type clinical <i>Pseudomonas aeruginosa</i> isolated from the sputum of adult patients with cystic fibrosis

Verified

Yuki Kakinuma, Colin E. Goldsmith, A. Watt, J.S. Elborn et al.

Journal: British Journal of Biomedical ScienceYear: 2010Citations: 2

"Molecular conservation within LES9F and PS21 Liverpool epidemic strain (LES) markers in wild-type clinical Pseudomonas aeruginosa isolated from the sputum of adult patients with cystic fibrosis." British Journal of Biomedical Science, 67(2), pp. 87–88

Health SciencesMedicinePulmonary and Respiratory Medicine
Read Source

Investigating the role of cathepsin S in the pathogenesis of cystic fibrosis-like lung disease

Verified

R.A. Brown, Small Dm, AA Abladey, LJ Holsinger et al.

Journal: PneumologieYear: 2016Citations: 1

Introduction: Elevated levels of the cysteine protease cathepsin S (cat S) are found in Cystic fibrosis (CF) lung secretions, however, the role of cat S in CF lung disease is unclear. Cat S is capable of maintaining its activity at a neutral pH allowing it to remain active outside of the cell. Conse...

Health SciencesMedicinePulmonary and Respiratory Medicine
Read Source

Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes

Verified

Michal Shteinberg, Joseph Rivlin, Michal Gur, Muriel Konopnicki et al.

Journal: LungYear: 2015Citations: 1

Haptoglobin (Hp), a heme-Iron chelator, has different isoforms which are associated with variable tendency toward infections: Hp 1-1, Hp 2-1, and Hp 2-2. Cystic fibrosis (CF) outcomes are variable and influenced by genetic and environmental factors. The aim of this study was to determine whether Hp ...

Health SciencesMedicinePulmonary and Respiratory Medicine
Read Source

S145 The impact of cigarette smoke extract on inflammatory responses and toll-like receptor-4 expression in healthy nasal epithelial cells

Verified

David Comer, J.S. Elborn, Vanessa Brown, Colleen M. McDowell et al.

Journal: ThoraxYear: 2010Citations: 1

Although cigarette smoke extract (CSE) is widely used in respiratory research, the methods used in its preparation are diverse and there is no consensus as to whether cigarette smoke extract (CSE) induces a pro-inflammatory or an immunosuppressive response in epithelial cells.1 Although the adverse ...

Health SciencesHealth ProfessionsEmergency Medical ServicesOpen Access
Read Source

S39 Polypharmacy in patients with non-cystic fibrosis bronchiectasis: the BRONCHUK observational study

Verified

Henil Upadhyay, Anthony De Soyza, Rosie Watson, Phil Mawson et al.

Year: 2025

<h3>Introduction</h3> BRONCHUK is a multicentre, prospective, observational cohort study enrolling adults with radiologically confirmed bronchiectasis across secondary centres in the UK. The objectives of the study are to develop a multicentre bronchiectasis registry incorporating baseline data coll...

Health SciencesMedicinePulmonary and Respiratory Medicine
Read Source

Is multimorbidity a clinical predictor of poor outcomes in bronchiectasis?:A BronchUK registry analysis

Verified

Anthony De Soyza, Rebecca Watson, Phil Mawson, Tom Shield et al.

Year: 2025

<bold>Introduction:</bold> Multimorbidity(MM) is associated with poor outcomes in the general population.The BACI index in bronchiectasis confirms certain comorbidities are adversely prognostic.We aimed to assess the prevalence,and association of MM with outcomes of death and hospitalisation. <bold>...

Health SciencesMedicineEpidemiology
Read Source

Airway Total Bacterial Density, Microbiota Community Composition and Relationship with Clinical Parameters in Bronchiectasis

Verified

Zina Alfahl, G.G. Einarsson, J.S. Elborn, D.F. Gilpin et al.

Journal: SSRN Electronic JournalYear: 2024
Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

A 2x2 factorial, randomised, open-label trial to determine the clinical and cost- effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: A protocol for the CLEAR clinical trial

Verified

Judy Bradley, Rohan Anand, Brenda O’Neill, Kathryn M. Ferguson et al.

Journal: Research SquareYear: 2019

Abstract Background: Current guidelines for the management of bronchiectasis (BE) highlight the lack of evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, to aid sputum-removal as part of standard care. We hypothesise that mucoactive agents (HTS or cabocistei...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

A 2x2 factorial, randomised, open-label trial to determine the clinical and cost- effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: A protocol for the CLEAR clinical trial

Verified

Judy Bradley, Rohan Anand, Brenda O’Neill, Kathryn M. Ferguson et al.

Journal: Research SquareYear: 2019

Abstract Background Current guidelines for the management of bronchiectasis (BE) highlight the lack of evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, to aid sputum-removal as part of standard care. We hypothesise that mucoactive agents (HTS or cabocistein...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

Investigating the role of cathepsin S in the pathogenesis of cystic fibrosis-like lung disease

Verified

Ryan Brown, Donna M. Small, Anthony Abladey, Leslie J. Holsinger et al.

Year: 2015

Elevated levels of the cysteine protease cathepsin S (cat S) are found in cystic fibrosis (CF) lung secretions, however, the role of cat S in CF lung disease is unclear. Cat S is capable of maintaining its activity at a neutral pH allowing it to remain active outside of the cell. Consequently, cat S...

Health SciencesMedicinePulmonary and Respiratory Medicine
Read Source

SELDI-TOF analysis of induced sputum from patients with lung cancer, ‘at risk’ control subjects and healthy control subjects

Verified

N. Magee, Robert D. Gray, M. Imrie, Ray W. Shepherd et al.

Journal: Lung CancerYear: 2008
Physical SciencesEngineeringBiomedical Engineering
Read Source

Ten year longitudinal change in lung function and C reactive protein in middle-aged men in Northern Ireland

Verified

Kathy McClean, Chris R. Cardwell, Frank Kee, Ian Young et al.

Journal: Research Portal (Queen's University Belfast)Year: 2007
Health SciencesMedicinePulmonary and Respiratory Medicine
Read Source
PreviousPage 2 of 2Next